Randall Michael Giuffre

This profile gathers the share dealings of Randall Michael Giuffre in DiaMedica Therapeutics Inc., where the filings describe the role as board member. The record holds 21 filings, for trades running from 11 December 2018 to 2 January 2026.

The open-market record is one-sided, with 11 purchases worth €514k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 7 share grants and 2 option exercises.

Half of the purchases are above €30k and half below. 11 out of 11 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

Most recently, on 6 January 2026, the filings show a share grant worth €44k in DiaMedica Therapeutics Inc. The last insider purchase was made public on 26 June 2023, 1,218 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.